NO20012220L - Adenovirus-mediert genterapi - Google Patents

Adenovirus-mediert genterapi

Info

Publication number
NO20012220L
NO20012220L NO20012220A NO20012220A NO20012220L NO 20012220 L NO20012220 L NO 20012220L NO 20012220 A NO20012220 A NO 20012220A NO 20012220 A NO20012220 A NO 20012220A NO 20012220 L NO20012220 L NO 20012220L
Authority
NO
Norway
Prior art keywords
adenovirus
gene therapy
mediated gene
useful
treatment
Prior art date
Application number
NO20012220A
Other languages
English (en)
Other versions
NO330776B1 (no
NO20012220D0 (no
Inventor
Seppo Yla-Herttuala
Anu-Maaria Sandmair
Sami Loimas
Matti Vapalahti
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20012220(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Publication of NO20012220L publication Critical patent/NO20012220L/no
Publication of NO20012220D0 publication Critical patent/NO20012220D0/no
Publication of NO330776B1 publication Critical patent/NO330776B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20012220A 1998-11-06 2001-05-04 Anvendelse av en adenovirus som har et funksjonelt thymidinkinase-gen, for fremstilling av et medikament for anvendelse i terapi av hjernetumor. NO330776B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9824437.9A GB9824437D0 (en) 1998-11-06 1998-11-06 Gene therapy
PCT/EP1999/009017 WO2000028059A1 (en) 1998-11-06 1999-11-05 Adenovirus-mediated gene therapy

Publications (3)

Publication Number Publication Date
NO20012220L true NO20012220L (no) 2001-05-04
NO20012220D0 NO20012220D0 (no) 2001-05-04
NO330776B1 NO330776B1 (no) 2011-07-11

Family

ID=10842035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012220A NO330776B1 (no) 1998-11-06 2001-05-04 Anvendelse av en adenovirus som har et funksjonelt thymidinkinase-gen, for fremstilling av et medikament for anvendelse i terapi av hjernetumor.

Country Status (18)

Country Link
US (1) US6579855B1 (no)
EP (1) EP1135513B2 (no)
JP (1) JP4733833B2 (no)
KR (1) KR20020013473A (no)
CN (1) CN1184321C (no)
AT (1) ATE341639T1 (no)
AU (1) AU749451B2 (no)
CA (1) CA2348624C (no)
CY (1) CY1106198T1 (no)
DE (1) DE69933468T3 (no)
DK (1) DK1135513T4 (no)
ES (1) ES2273521T5 (no)
GB (1) GB9824437D0 (no)
HU (1) HUP0104046A3 (no)
NO (1) NO330776B1 (no)
PL (1) PL193076B1 (no)
PT (1) PT1135513E (no)
WO (1) WO2000028059A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910950D0 (en) 2009-06-24 2009-08-05 Ark Therapeutics Ltd Filtration
GB0916997D0 (en) * 2009-09-28 2009-11-11 Ark Therapeutics Ltd Combination therapy
US20130296407A1 (en) * 2011-01-18 2013-11-07 Ark Therapeutics, Ltd. Combination Therapy for Cancer
GB201100804D0 (en) * 2011-01-18 2011-03-02 Ark Therapeutics Ltd Drug combination
WO2013119880A1 (en) 2012-02-07 2013-08-15 Global Bio Therapeutics Usa, Inc. Compartmentalized method of nucleic acid delivery and compositions and uses thereof
US20160058888A1 (en) * 2013-05-08 2016-03-03 Gliotherapy Limited Treatment of Operable High-Grade Glioma With Sitimagene Ceradenovec Gene Therapy and Ganciclovir
US11364032B2 (en) 2013-08-08 2022-06-21 Global Bio Therapeutics, Inc. Clamp device for minimally invasive procedures and uses thereof
DE102019000490A1 (de) 2019-01-23 2020-07-23 HAEMES Verwaltungsgesellschaft mbH Verwendung von Oligonukleotiden für die Behandlung von Tumoren
AU2020407233A1 (en) 2019-12-20 2022-08-18 Regeneron Pharmaceuticals, Inc. Novel IL2 agonists and methods of use thereof
CA3183151A1 (en) 2020-05-12 2021-11-18 Regeneron Pharmaceuticals, Inc. Novel il10 agonists and methods of use thereof
CN117597365A (zh) 2021-05-04 2024-02-23 再生元制药公司 多特异性fgf21受体激动剂及其应用
WO2023004282A2 (en) 2021-07-19 2023-01-26 Regeneron Pharmaceuticals, Inc. Il12 receptor agonists and methods of use thereof
CA3238029A1 (en) 2021-11-11 2023-05-19 Regeneron Pharmaceuticals, Inc. Cd20-pd1 binding molecules and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662441B2 (ja) * 1986-02-18 1994-08-17 花王株式会社 抗腫瘍物質徐放性製剤
US5631236A (en) * 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk

Also Published As

Publication number Publication date
CN1325450A (zh) 2001-12-05
CA2348624C (en) 2012-07-31
DK1135513T4 (da) 2011-11-21
EP1135513A1 (en) 2001-09-26
DE69933468T2 (de) 2007-01-11
ES2273521T3 (es) 2007-05-01
DE69933468T3 (de) 2012-01-19
AU1385100A (en) 2000-05-29
JP4733833B2 (ja) 2011-07-27
DK1135513T3 (da) 2006-11-27
NO330776B1 (no) 2011-07-11
CY1106198T1 (el) 2011-06-08
PL349489A1 (en) 2002-07-29
DE69933468D1 (de) 2006-11-16
EP1135513B2 (en) 2011-08-10
ES2273521T5 (es) 2011-12-28
HUP0104046A3 (en) 2003-09-29
KR20020013473A (ko) 2002-02-20
ATE341639T1 (de) 2006-10-15
AU749451B2 (en) 2002-06-27
GB9824437D0 (en) 1999-01-06
PL193076B1 (pl) 2007-01-31
HUP0104046A2 (hu) 2002-01-28
CA2348624A1 (en) 2000-05-18
WO2000028059A1 (en) 2000-05-18
EP1135513B1 (en) 2006-10-04
CN1184321C (zh) 2005-01-12
US6579855B1 (en) 2003-06-17
NO20012220D0 (no) 2001-05-04
JP2002529097A (ja) 2002-09-10
PT1135513E (pt) 2006-12-29

Similar Documents

Publication Publication Date Title
CY1106198T1 (el) Γονιδιακη θepαπεια που διαμεσολαβειται απο αδενοϊο
DE69735643D1 (de) IL12 zur Gentherapie der Tumoren
AU1939200A (en) Electrochemical treatment of malignant tumors
JO2248B1 (en) Pirazolobenzodiazepines
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
DE60041333D1 (de) Hen prostatkrebs exprimiert wird, und deren verwendungen
AU2882299A (en) Anti-asthma therapy
AU3891299A (en) Combination therapy for treatment of depression
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
AU3552399A (en) Recombinant poliovirus for the treatment of cancer
AU1264200A (en) Use of neoangiogenesis markers for diagnosing and treating tumours by therapy
DE59510240D1 (de) Hochfrequenztherapieeinrichtung zur interstitiellen Thermotherapie von Tumoren
FI962114A (fi) Yhdistelmä-DNA-adenoviruksia syöpien geeniterapiaan
NO20006047D0 (no) Fremgangsmåte for genterapi
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
DE69738803D1 (de) Apoptosis induzierendes protein und dieses kodierendes gen
ZA200110436B (en) Therapeutic use of melatonin.
MXPA02001204A (es) Compuestos calciliticos.
HUP0101947A3 (en) Combination for the treatment of tumors
IS5481A (is) Samsett meðferð til meðhöndlunar á alnæmi
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
PT1064014E (pt) Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus
AU5778399A (en) Gene therapy for treatment of cancer
HU9700425D0 (en) Use of incubated, citrate-containing leukaemic blood-product for treating tumors
ZA992063B (en) Suicide gene therapy system for the treatment of brain tumours.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees